ddd107498 has been researched along with Malaria--Falciparum* in 1 studies
1 other study(ies) available for ddd107498 and Malaria--Falciparum
Article | Year |
---|---|
Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.
Antimalarial drug resistance in the Topics: Animals; Antimalarials; Drug Resistance; Drug Therapy, Combination; Hemeproteins; Malaria, Falciparum; Mice; Mice, SCID; Naphthyridines; Peptide Elongation Factor 2; Plasmodium falciparum; Quinolines | 2020 |